retatrutide clinical trial results weight loss efficacy VisualAbstract: reduces body by 17.5% in patients with obesity Retatrutide for weight loss: Study

The SURPASS-CVOT trial evaluated tirzepatide in 13,299 T2DM patients with high CVD risk

The synergy between cagrilintide and semaglutide is not merely additive

The Precision Peptide Genetic Test also evaluates metabolic predisposition variants (FTO rs9939609, MC4R rs17782313) that relate to weight regulation and appetite signaling

The host and gut microbes exist in a symbiotic relationship, in which the host creates a nutrient-rich environment for microbes, and the microbes, in turn, impact host physiology, immunology, and metabolism 239

Weight Loss Drugs Coverage

Second, the combination of GLP-1 medication with testosterone optimization creates a treatment approach that is uniquely relevant to men dealing with weight gain and declining hormonal levels simultaneously